Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients
Purpose. To examine the effect of a pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. Methods. A total of 200 elderly (> 60 years) diabetic and/or hypertensive patients were recruited into a randomized, controlled, prospective clinical...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2011-06-01
|
| Series: | Journal of Pharmacy & Pharmaceutical Sciences |
| Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/10047 |
| _version_ | 1827165131912511488 |
|---|---|
| author | Paulo Roque Obreli Neto Srecko Marusic Divaldo Pereira de Lyra Júnior Diogo Pilger Joice Mara Cruciol-Souza Walderez Penteado Gaeti Roberto Kenji Nakamura Cuman |
| author_facet | Paulo Roque Obreli Neto Srecko Marusic Divaldo Pereira de Lyra Júnior Diogo Pilger Joice Mara Cruciol-Souza Walderez Penteado Gaeti Roberto Kenji Nakamura Cuman |
| author_sort | Paulo Roque Obreli Neto |
| collection | DOAJ |
| description | Purpose. To examine the effect of a pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. Methods. A total of 200 elderly (> 60 years) diabetic and/or hypertensive patients were recruited into a randomized, controlled, prospective clinical trial with a 36-month follow-up, developed in a public primary health care unit in a municipality in the Brazilian State of Sao Paulo. A range of clinical measurements were evaluated at the baseline and up to 36 months afterwards. The intervention group patients received pharmaceutical care from a clinical pharmacist, whereas the control group patients received their usual care from the medical and nursing staff. The Framingham scoring method was used to estimate changes in the 10-year coronary heart disease risk scores of all the patients. Results. A total of 194 patients completed the study. Significant reductions (p < 0.05) in the mean values (baseline vs. 36 months) for the systolic blood pressure [156.7mmHg vs 133.7mmHg; p |
| first_indexed | 2024-03-12T08:30:49Z |
| format | Article |
| id | doaj.art-76487a8be02b43abbe6deabd0aa9856c |
| institution | Directory Open Access Journal |
| issn | 1482-1826 |
| language | English |
| last_indexed | 2025-03-21T01:27:38Z |
| publishDate | 2011-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Journal of Pharmacy & Pharmaceutical Sciences |
| spelling | doaj.art-76487a8be02b43abbe6deabd0aa9856c2024-08-03T01:10:26ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262011-06-0114210.18433/J3259QEffect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive PatientsPaulo Roque Obreli Neto0Srecko Marusic1Divaldo Pereira de Lyra Júnior2Diogo Pilger3Joice Mara Cruciol-Souza4Walderez Penteado Gaeti5Roberto Kenji Nakamura Cuman6Department of Pharmacology and Therapeutics, State University of Maringá, Maringá, PRDepartment of Clinical Pharmacology, University Hospital Dubrava, ZagrebLaboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, SEDepartment of Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RSDepartment of Pharmaceutical Sciences, State University of LondrinaDepartment of Pharmacology and Therapeutics, State University of Maringá, Maringá, PRDepartment of Pharmacology and Therapeutics, State University of Maringá, Maringá, PRPurpose. To examine the effect of a pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. Methods. A total of 200 elderly (> 60 years) diabetic and/or hypertensive patients were recruited into a randomized, controlled, prospective clinical trial with a 36-month follow-up, developed in a public primary health care unit in a municipality in the Brazilian State of Sao Paulo. A range of clinical measurements were evaluated at the baseline and up to 36 months afterwards. The intervention group patients received pharmaceutical care from a clinical pharmacist, whereas the control group patients received their usual care from the medical and nursing staff. The Framingham scoring method was used to estimate changes in the 10-year coronary heart disease risk scores of all the patients. Results. A total of 194 patients completed the study. Significant reductions (p < 0.05) in the mean values (baseline vs. 36 months) for the systolic blood pressure [156.7mmHg vs 133.7mmHg; phttps://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/10047 |
| spellingShingle | Paulo Roque Obreli Neto Srecko Marusic Divaldo Pereira de Lyra Júnior Diogo Pilger Joice Mara Cruciol-Souza Walderez Penteado Gaeti Roberto Kenji Nakamura Cuman Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients Journal of Pharmacy & Pharmaceutical Sciences |
| title | Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients |
| title_full | Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients |
| title_fullStr | Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients |
| title_full_unstemmed | Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients |
| title_short | Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients |
| title_sort | effect of a 36 month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients |
| url | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/10047 |
| work_keys_str_mv | AT pauloroqueobrelineto effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT sreckomarusic effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT divaldopereiradelyrajunior effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT diogopilger effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT joicemaracruciolsouza effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT walderezpenteadogaeti effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients AT robertokenjinakamuracuman effectofa36monthpharmaceuticalcareprogramonthecoronaryheartdiseaseriskinelderlydiabeticandhypertensivepatients |